Blog

Polymorphism in API

In pharmaceuticals, an Active Pharmaceutical Ingredient (API) refers to the biologically active component of a drug product. When it comes to APIs, polymorphism plays a crucial role in determining the drug’s overall properties and performance.

Polymorphs of an API

Polymorphism in APIs refers to the existence of multiple crystalline forms of the same chemical substance. These polymorphs have the same chemical composition but different molecular packing or arrangements within their crystal lattice, which can lead to varying physicochemical properties such as:

1. Solubility: Different polymorphs of an API can have different solubilities in the same solvent. For oral medications, a more soluble polymorph might result in better bioavailability.
2. Dissolution Rate: The rate at which the API dissolves can vary between polymorphs. Faster-dissolving polymorphs might lead to quicker onset of action.
3. Stability: Some polymorphs may be thermodynamically more stable under given conditions (e.g., temperature, humidity). A more stable form is typically preferred to ensure the drug remains effective over time.
4. Melting Point: Polymorphs can exhibit different melting points, which is important for drug formulation processes that involve heat (e.g., tableting, capsule filling).
5. Mechanical Properties: The ability of an API to be compressed into tablets or its behavior during grinding or milling can be affected by its polymorph. This impacts the drug manufacturing process.

Example of API Polymorphism:

• Ritonavir: One of the most well-known cases of API polymorphism. After initial drug approval, a more stable polymorph was discovered, which had much lower solubility than the original form. This polymorphic shift led to formulation challenges and the need for drug reformulation.
• Carbamazepine: An anti-epileptic drug, has several polymorphic forms. The different forms exhibit variations in their dissolution rates, which can influence the drug’s therapeutic effects.

Importance of Polymorphism in API Development:

1. Regulatory Requirements: Regulatory bodies, such as the FDA and EMA, require thorough characterization of all possible polymorphs during drug development. This ensures that the chosen form of the API is optimal for patient use.
2. Patent Implications: Different polymorphs can be separately patented, allowing for extended intellectual property protection even after the original patent for the API expires.
3. Formulation and Manufacturing Control: During drug production, maintaining control over the polymorphic form of the API is essential to ensure batch-to-batch consistency and to avoid unwanted transformations during storage.

In conclusion, polymorph selection and control in APIs are critical for the development, manufacturing and performance of pharmaceutical products.